Consequently, the refunctioned DCs can expand and stimulate cytotoxicity T cells, boosting the anti‐tumor immune responses.[130] Insufficient activation of the MHC system limits the efficacy of cancer immunotherapy. This evidence concerns the gene HLA-C and neoplasm.